MIST Stock Summary and Trading Ideas (Milestone Pharmaceuticals - Common Shares | NASDAQ:MIST)

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Milestone Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol MIST.

As of September 2, 2026, MIST stock price climbed to $1.18 with 753,345 million shares trading.

MIST has a beta of 3.53, meaning it tends to be more sensitive to market movements. MIST has a correlation of 0.28 to the broad based SPY ETF.

MIST has a market cap of $146.91 million. This is considered a Micro Cap stock.

Last quarter Milestone Pharmaceuticals - Common Shares reported $559,000 in Revenue and -$.21 earnings per share. This fell short of revenue expectation by $-254,336 and missed earnings estimates by -$.02.

In the last 3 years, MIST traded as high as $3.52 and as low as $.63.

The top ETF exchange traded funds that MIST belongs to (by Net Assets): GWX.

MIST has underperformed the market in the last year with a return of -35.9%, while the SPY ETF gained +19.8%. In the last 3 month period, MIST fell short of the market, returning -13.2%, while SPY returned +1.1%. However, in the most recent 2 weeks MIST has outperformed the stock market by returning +10.3%, while SPY returned -0.3%.

MIST support price is $1.09 and resistance is $1.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIST shares will trade within this expected range on the day.